 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for KCNK7 |
 Gene summary |
| Basic gene information | Gene symbol | KCNK7 |
| Gene name | potassium channel, subfamily K, member 7 | |
| Synonyms | K2p7.1|TWIK3 | |
| Cytomap | UCSC genome browser: 11q13 | |
| Type of gene | protein-coding | |
| RefGenes | NM_005714.1, NM_033347.1,NM_033348.1,NM_033455.1,NM_033456.1, | |
| Description | potassium channel subfamily K member 7two pore domain K+ channel | |
| Modification date | 20141217 | |
| dbXrefs | MIM : 603940 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000173338 | ||
| HPRD : 06804 | ||
| Vega : OTTHUMG00000166528 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_KCNK7 | |
| BioGPS: 10089 | ||
| Pathway | NCI Pathway Interaction Database: KCNK7 | |
| KEGG: KCNK7 | ||
| REACTOME: KCNK7 | ||
| Pathway Commons: KCNK7 | ||
| Context | iHOP: KCNK7 | |
| ligand binding site mutation search in PubMed: KCNK7 | ||
| UCL Cancer Institute: KCNK7 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | HPA,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Skin | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | SKCM | |
| Reference showing the relevant tissue of KCNK7 | ||
| Description by TissGene annotations | Have significant anti-correlated miRNA | |
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for KCNK7 |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| HNSC | 2.465495125 | 3.605025357 | -1.139530233 | 0.0114 | 0.027699784 |
| Top |
| TissGene-miRNA for KCNK7 |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| LUAD | hsa-miR-424-5p | MIMAT0001341 | 0.044 | -0.26 | 60 |
| LUAD | hsa-miR-15a-5p | MIMAT0000068 | 0.035 | -0.28 | 60 |
| UCS | hsa-miR-133b | MIMAT0000770 | 0.018 | -0.32 | 56 |
| Top |
| TissGeneMut for KCNK7 |
| TissGeneSNV for KCNK7 |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.P6L | COAD | 1 |
| p.G285R | LUAD | 1 |
| p.M123T | LGG | 1 |
| p.K253N | HNSC | 1 |
| p.P131L | STAD | 1 |
| p.R222H | BLCA | 1 |
| p.P296T | SARC | 1 |
| p.D257N | SKCM | 1 |
| p.S115L | COAD | 1 |
| p.A264V | LGG | 1 |
| p.M123K | LUAD | 1 |
| p.R263H | LUAD | 1 |
| p.G223S | STAD | 1 |
| p.E278K | LUAD | 1 |
| p.K253N | BLCA | 1 |
| p.F269L | BRCA | 1 |
| p.V137M | COAD | 1 |
| p.S79F | SKCM | 1 |
| p.A297T | PRAD | 1 |
| p.R9* | TGCT | 1 |
| p.E32D | COAD | 1 |
| p.R9X | TGCT | 1 |
| p.A25T | SARC | 1 |
| p.A298T | ACC | 1 |
| p.L246F | HNSC | 1 |
| p.G221S | UCEC | 1 |
| p.E278K | BLCA | 1 |
| p.R222C | STAD | 1 |
| p.K253N | PAAD | 1 |
| p.P271T | STAD | 1 |
| Top |
| TissGeneCNV for KCNK7 |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for KCNK7 |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | FusionScan | LGG | TCGA-VM-A8CD-01A | SEC24A-KCNK7 | In-Frame | chr5:133984863 | chr11:65361345 |
| Chimerdb3.0 | TopHat-Fusion | LGG | TCGA-VM-A8CD-01A | SEC24A-KCNK7 | In-Frame | chr5:133984862 | chr11:65361344 |
| Top |
| TissGeneNet for KCNK7 |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for KCNK7 |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for KCNK7 |
| TissGeneDrug for KCNK7 |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for KCNK7 |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |